- Home
- BHFAP vs PBH Comparison
BHFAP vs PBH Comparison
Compare BHFAP & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHFAP
- PBH
- Stock Information
- Founded
- BHFAP N/A
- PBH 1996
- Country
- BHFAP United States
- PBH United States
- Employees
- BHFAP 1400
- PBH N/A
- Industry
- BHFAP Life Insurance
- PBH Biotechnology: Pharmaceutical Preparations
- Sector
- BHFAP Finance
- PBH Health Care
- Exchange
- BHFAP Nasdaq
- PBH Nasdaq
- Market Cap
- BHFAP N/A
- PBH 4.1B
- IPO Year
- BHFAP N/A
- PBH 2005
- Fundamental
- Price
- BHFAP $19.60
- PBH $87.06
- Analyst Decision
- BHFAP
- PBH Buy
- Analyst Count
- BHFAP 0
- PBH 5
- Target Price
- BHFAP N/A
- PBH $94.00
- AVG Volume (30 Days)
- BHFAP N/A
- PBH 368.1K
- Earning Date
- BHFAP N/A
- PBH 05-08-2025
- Dividend Yield
- BHFAP N/A
- PBH N/A
- EPS Growth
- BHFAP N/A
- PBH 2.88
- EPS
- BHFAP N/A
- PBH 4.29
- Revenue
- BHFAP N/A
- PBH $1,137,762,000.00
- Revenue This Year
- BHFAP N/A
- PBH $1.48
- Revenue Next Year
- BHFAP N/A
- PBH $2.28
- P/E Ratio
- BHFAP N/A
- PBH $20.26
- Revenue Growth
- BHFAP N/A
- PBH 1.10
- 52 Week Low
- BHFAP N/A
- PBH $62.35
- 52 Week High
- BHFAP N/A
- PBH $90.04
- Technical
- Relative Strength Index (RSI)
- BHFAP 48.24
- PBH 62.76
- Support Level
- BHFAP $19.40
- PBH $80.62
- Resistance Level
- BHFAP $20.24
- PBH $84.90
- Average True Range (ATR)
- BHFAP 0.43
- PBH 2.17
- MACD
- BHFAP 0.11
- PBH 0.57
- Stochastic Oscillator
- BHFAP 63.54
- PBH 97.20
About BHFAP Brighthouse Financial Inc.
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.